Drug use in the nursing home

Annals of Internal Medicine

Volumn 123, Issue 3, 1995, Pages 195-204

  Avorn, Jerry ^a   Gurwitz, Jerry H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CALCIUM; CARDIOVASCULAR AGENT; CIMETIDINE; COLECALCIFEROL; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; LAXATIVE; NITROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; PSYCHOTROPIC AGENT; UREA; VITAMIN;

CLINICAL TRIAL; COST CONTROL; DEMENTIA; DEPRESSION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG USE; EXERCISE; EXTRAPYRAMIDAL SYMPTOM; HIP FRACTURE; HUMAN; HYPOTENSION; LONG TERM CARE; NEPHROTOXICITY; NEUROTOXICITY; NURSING HOME; PAIN; PRIORITY JOURNAL; REVIEW; SLEEP; SOMNOLENCE; STOMACH DISEASE; TUBERCULOSIS;

EID: 0029127473     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-3-199508010-00007     Document Type: Review

References (85)

1. Ostrom JR, Hammarlund ER, Christensen DB, Plein JB, Kethley AJ. Medication usage in an elderly population. Med Care. 1985;23:157-64.
2. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992;47:M137-44.
3. Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684-9.
4. Beers M, Avorn J, Soumerai SB, Everitt DE, Sherman DS, Salem S. Psychoactive medication use in intermediate-care facility residents. JAMA. 1988;260:3016-20.
5. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-32.
6. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292-6.
7. Gurwitz JH. Suboptimal medication use in the elderly. The tip of the iceberg [Editorial]. JAMA. 1994; 272:316-7.
8. Beers MH, Dang J, Hasegawa J, Tamai IY. Influence of hospitalization on drug therapy in the elderly. J Am Geriatr Soc. 1989;37:679-83.
9. Yusuf S, Garg R, Held P, Gorlin R. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. Am J Cardiol. 1992;69:64G-70G.
10. Forman DE, Coletta D, Kenny D, Kosowsky BD, Stoukides J, Rohrer M, et al. Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med. 1991;151:2194-8.
11. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med. 1993;329:I-7.
12. Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins Univ Pr; 1979.
13. Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med. 1987;317:722-8.
14. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M, Sykora K, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986;315:854-9.
15. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263:1653-7.
16. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-66.
17. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc. 1990;38:542-52.
18. Conditions of participation - pharmaceutical services. Federal Register. 1974;39:12-7.
19. Winograd CH, Pawlson LG. OBRA 87 - a commentary. J Am Geriatr Soc. 1991;39:724-6.
20. Elon R, Pawlson LG. The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc. 1992;40:958-63.
21. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of OBRA-87 regulations. JAMA. 1994;271:358-62.
22. Hing E, Bloom B. Long-term care for the functionally dependent elderly. Vital Health Stat. 1990;13:1-50.
23. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38:553-63.
24. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3d. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316:363-9.
25. Avorn J, Monane M, Everitt DE, Beers MH, Fields D. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication. Arch Intern Med. 1994;154:1113-7.
26. Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt DE, et al. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med. 1995; [In press].
27. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989;262:3303-7.
28. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-73.
29. Greenblatt DJ, Allen MD, Shader RI. Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther. 1977;21:355-61.
30. Garrard J, Makris L, Dunham T, Heston LL, Cooper S, Ratner ER, et al. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA. 1991;265:463-7.
31. Rovner BW, Edelman BA, Cox MP, Shmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry. 1992;149:1390-2.
32. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327:168-73.
33. Everitt DE, Fields DR, Soumerai SS, Avorn J. Resident behavior and staff distress in the nursing home. J Am Geriatr Soc. 1991;39:792-8.
34. Ray WA, Taylor JA, Meador KG, Lichtenstein MJ, Griffin MR, Fought R, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med. 1993;153:713-21.
35. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health. 1980;70:485-91.
36. Svarstad BL, Mount JK. Nursing home resources and tranquilizer use among the institutionalized elderly. J Am Geriatr Soc. 1991;39:869-75.
37. Lohr JB, Jeste DV, Harris MJ, Salzman C. Treatment of disordered behavior. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. Second edition. Baltimore: Williams & Wilkins; 1992:79-113.
38. Greenblatt DJ. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry. 1991;52(Suppl):4-10.
39. Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI. Sensitivity to triazolam in the elderly. N Engl J Med. 1991;324:1691-8.
40. Monane M, Avorn J, Beers MH, Everitt DE. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med. 1993;153:633-8.
41. Parmelee PA, Katz IR, Lawton MP. Depression among institutionalized aged: assessment and prevalence estimation. J Gerontol. 1989;44: M22-9.
42. Parmelee PA, Katz IR, Lawton MP. Incidence of depression in long-term care settings. J Gerontol. 1992;47:M189-96.
43. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF. Depression and mortality in nursing homes. JAMA. 1991;265:993-6.
44. Heston LL, Garrard J, Makris L, Kane RL, Cooper S, Dunham T, et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc. 1992;40:1117-22.
45. Psychotherapeutie medications in the nursing home. Board of Directors of the American Association for Geriatric Psychiatry, Clinical Practice Committee of the American Geriatrics Society, and Committee on Long-Term Care and Treatment for the Elderly, American Psychiatric Association. J Am Geriatr Soc. 1992;40:946-9.
46. Tallis R. How long should elderly patients take antidepressants? Lancet. 1993;341:1444-5.
47. Koenig HG, Goli V, Shelp F, Kudler HS, Cohen HJ, Meador KG, et al. Antidepressant use in elderly medical inpatients: lessons from an attempted clinical trial. J Gen Intern Med. 1989;4:498-505.
48. Gerson SC, Plotkin DA, Jarvik LF. Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacol. 1988;8:311-22.
49. How long should elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Old Age Depression Interest Group. Br J Psychiatry. 1993;162:175-82.
50. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA. 1993; 269:2673-5.
51. Brymer C, Winograd CH. Fluoxetine in elderly patients: is there cause for concern? J Am Geriatr Soc. 1992;40:902-5.
52. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ. 1993;306:683-7.
53. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325:87-91.
54. Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA. 1990;264:471-5.
55. Bollini P, Rodriguez LA, Perez Gutthann SP, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med. 1992;152:1289-95.
56. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-84.
57. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994;272:781-6.
58. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA. 1994;272:1845-50.
59. Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc. 1994;42:947-52.
60. Smith B. Effect of irritant purgatives on myenteric plexus in man and the mouse. Gut. 1968;9:139-43.
61. Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. J Am Geriatr Soc. 1993;41:1130-40.
62. Lederle FA, Busch DL, Mattox KM, West MJ, Aske DM. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med. 1990;89:597-601.
63. Castle SC, Cantrell M, Israel DS, Samuelson MJ. Constipation prevention: empiric use of stool softeners questioned. Geriatrics. 1991;46: 84-6.
64. United States Public Health Service. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: U.S. Department of Health and Human Services, Public Health Service; 1991: DHHS Publication (PHS) 91-50212.
65. McBean AM, Babish JD, Prihoda R. The utilization of pneumococcal vaccine among elderly Medicare beneficiaries, 1985 through 1988. Arch Intern Med. 1991;151:2009-16.
66. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med. 1985;312:1483-7.
67. Stead WW, Dutt AK. Tuberculosis: a special problem in the elderly. In: Hazzard WR, Andres R. Bierman EL, Blass JP, Ettinger WH, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. Third edition. New York: McGraw-Hill; 1994:575-82.
68. Stead WW, To T, Harrison RW, Abraham JH 3d. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med. 1987;107:843-5.
69. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637-42.
70. Heaney RP. Thinking straight about calcium [Editorial]. N Engl J Med. 1993;328:503-5.
71. Ray WA, Griffin MR, Downey W, Melton LG 3d. Long-term use of thiazide diuretics and risk of hip fracture. Lancet. 1989; 1:687-90.
72. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med. 1990;322:286-90.
73. Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991;115:1-6.
74. Ray WA. Thiazide diuretics and osteoporosis: time for a clinical trial? [Editorial] Ann Intern Med. 1991;115:64-5.
75. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-6.
76. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis [Editorial]. N Engl J Med. 1993;329:1192-3.
77. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-69.
78. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272:1335-40.
79. Hulley SB, Newman TB. Cholesterol in the elderly. Is it important? [Editorial]. JAMA. 1994;272:1372-4.
80. Sherman DS, Avorn J, Campion EW. Cimetidine use in nursing homes: prolonged therapy and excessive doses. J Am Geriatr Soc. 1987;35:1023-7.
81. 2-receptor antagonists in the long-term-care setting. J Am Geriatr Soc. 1992;40:359-64.
82. 2-receptor antagonists in the nursing home [Editorial]. J Am Geriatr Soc. 1992;40:425-6.
83. Richter JM, Colditz GA, Huse DM, Delea TE, Oster G. Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy. Am J Med. 1989;87:278-84.
84. 2-receptor antagonists. Standard therapy for acid-peptic diseases. 1. N Engl J Med. 1990;323:1672-80.
85. Avorn J. Reporting drug side effects: signals and noise [Editorial]. JAMA. 1990;263:1823.